TURTLE CAMERON enters SPYRE THERAPEUTICS, INC. with 576.70K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/30/2023ACC: 0000950170-23-031168
DirectorOfficer· Chief Executive Officer
Since Mar 2026
576.70K
Baseline shares
100% direct
576.70K
Direct ownership
1 position
65.38M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned576.70K
Total
576.70K direct576.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 576.70K | Direct |
| Total | 576.70K | 576.70K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
47.30M
Shares owned
N/A
Exercise price
0.3
Expiration
—
Exercise window
—
Series A Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
18.09M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
65.38M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.3 | — | — | 47.30M | N/A |
| Series A Preferred Stock Direct | Common Stock | — | — | 18.09M | N/A | |
| Total | 65.38M | 0.00 | ||||